| Ytd | -58.59% | |
| 1y | -65.87% |
| Open | 0.62 | Prev Close | 0.64 | Low | 0.62 | High | 0.63 | Mkt Cap | 801.09K |
| Vol | 5.87K | Avg Vol | 189.06K | EPS | -2.71 | P/E | -0.24 | Forward P/E | N/A |
| Beta | -0.32 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.12 | 200-d Avg | 11.86 | 1yr Est | 0.00 |
APUS News
Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-mar
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 pe
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) today announced a comprehensive settlement with Inscobe
https://www.sec.gov/ix?doc=/Archives/edgar/data/1894525/000121390026052036/ea0289213-8k_apimeds.htm
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 per
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
MindWave Innovations Inc., a Delaware corporation and wholly owned subsidiary of Apimeds Pharmaceuti
Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per